SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $86,441,000 | -26.0% | 1,521,580 | -2.6% | 0.10% | -30.4% |
Q1 2021 | $116,884,000 | -15.2% | 1,561,573 | -2.0% | 0.15% | -11.9% |
Q4 2020 | $137,805,000 | +57.3% | 1,592,933 | +11.1% | 0.17% | +35.5% |
Q3 2020 | $87,612,000 | +73.4% | 1,433,449 | +17.9% | 0.12% | +53.1% |
Q2 2020 | $50,538,000 | +101.3% | 1,215,429 | +39.1% | 0.08% | +50.0% |
Q1 2020 | $25,102,000 | -40.6% | 874,039 | +49.3% | 0.05% | -27.0% |
Q4 2019 | $42,263,000 | -48.1% | 585,439 | +0.9% | 0.07% | -51.9% |
Q3 2019 | $81,376,000 | -24.2% | 580,057 | -1.1% | 0.15% | -22.2% |
Q2 2019 | $107,418,000 | +20.1% | 586,696 | +4.3% | 0.20% | +12.5% |
Q1 2019 | $89,430,000 | +272.8% | 562,278 | +124.5% | 0.18% | +225.9% |
Q4 2018 | $23,989,000 | – | 250,431 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 99,306 | $14,027,000 | 5.76% |
Casdin Capital, LLC | 312,000 | $44,070,000 | 5.36% |
Palo Alto Investors LP | 840,372 | $118,703,000 | 4.80% |
BB BIOTECH AG | 1,071,373 | $151,331,000 | 4.00% |
TRV GP II, LLC | 37,362 | $5,277,000 | 3.10% |
Eversept Partners, LP | 43,621 | $6,161,466 | 2.70% |
RA Capital Management | 350,933 | $49,569,000 | 2.65% |
Eventide Asset Management | 494,000 | $69,778,000 | 2.56% |
OAK RIDGE INVESTMENTS LLC | 241,099 | $34,055,000 | 1.88% |
SUFFOLK CAPITAL MANAGEMENT LLC | 93,000 | $13,136,000 | 1.87% |